| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 25,627 | 6,916 | 30,788 | 38,702 | | Cost of Revenue | 6,830 | 2,793 | 8,098 | 11,205 | | | Gross Profit | 18,797 | 4,123 | 22,690 | 27,498 | | | Operating Expenses | | Research Development | 419 | 934 | 684 | 797 | | Selling General and Administrative | 10,150 | 16,489 | 17,037 | 18,870 | | Non Recurring |
-
| 23,867 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,228 | (37,167) | 4,969 | 7,831 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 38 | 47 | 47 | 48 | | Earnings Before Interest And Taxes | 8,266 | (37,120) | 5,016 | 7,879 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 8,266 | (37,120) | 5,016 | 7,879 | | Income Tax Expense | 3,188 | (14,287) | 1,879 | 3,128 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,078 | (22,832) | 3,137 | 4,751 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,078 | (22,832) | 3,137 | 4,751 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,078 | ($22,832) | $3,137 | $4,751 |
|
0.11% Nasdaq 
0.01%
Income Statement
